![Katherine Bishop](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Katherine Bishop
Direttore/Membro del Consiglio presso
DTx Pharma, Inc.
Profilo
Katherine M.
Bishop is currently the Director at DTx Pharma, Inc. since 2022 and the SVP, Head-Rare Disease & External Innovation at ACADIA Pharmaceuticals, Inc. since 2021.
Previously, she worked as the Director-Preclinical Research & Development at Ceregene, Inc. from 2001 to 2009, Vice President-Clinical Development at Ionis Pharmaceuticals, Inc. from 2009 to 2015, Chief Scientific Officer at Tioga Pharmaceuticals, Inc. in 2015, Chief Scientific Officer at Otonomy, Inc. from 2017 to 2019, and Chief Scientific Officer at Locanabio, Inc. from 2019 to 2020.
Dr. Bishop holds a doctorate degree from the University of Alberta, and undergraduate degrees from the University of British Columbia and Simon Fraser University.
Posizioni attive di Katherine Bishop
| Società | Posizione | Inizio |
|---|---|---|
DTx Pharma, Inc.
 DTx Pharma, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops siRNA therapies for neuroscience indications | Direttore/Membro del Consiglio | 02/05/2022 |
Precedenti posizioni note di Katherine Bishop
| Società | Posizione | Fine |
|---|---|---|
| ACADIA PHARMACEUTICALS INC. | Direttore Tecnico/Scientifico/R&S | - |
Locanabio, Inc.
 Locanabio, Inc. Packaged SoftwareTechnology Services Develops and operates software platform for addressing a wide spectrum of human genetic diseases | Direttore Tecnico/Scientifico/R&S | 01/12/2020 |
| OTONOMY | Direttore Tecnico/Scientifico/R&S | 01/07/2019 |
Tioga Pharmaceuticals, Inc.
 Tioga Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for the treatment of gastrointestinal diseases | Direttore Tecnico/Scientifico/R&S | 01/11/2016 |
| IONIS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/04/2015 |
Formazione di Katherine Bishop
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
71
Relazioni di 1° grado
10
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 10 |
|---|---|
Ionis Pharmaceuticals, Inc.
 Ionis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops antisense drugs | Health Technology |
ACADIA Pharmaceuticals, Inc.
 ACADIA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals drugs for treatment of central nervous system disorders | Health Technology |
Ceregene, Inc.
 Ceregene, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for neurodegenerative disorders | Health Technology |
Tioga Pharmaceuticals, Inc.
Tioga Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for the treatment of gastrointestinal diseases | Health Technology |
University of Alberta
 University of Alberta Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of British Columbia
 University of British Columbia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Simon Fraser University
 Simon Fraser University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Otonomy, Inc.
 Otonomy, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapeutics for neurology diseases | Health Technology |
DTx Pharma, Inc.
DTx Pharma, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops siRNA therapies for neuroscience indications | Health Technology |
Locanabio, Inc.
Locanabio, Inc. Packaged SoftwareTechnology Services Develops and operates software platform for addressing a wide spectrum of human genetic diseases | Technology Services |
